Zobrazeno 1 - 10
of 29
pro vyhledávání: ''
Autor:
Lili Feng, Yi Chang, Ying Chu, Shengjun Wang, Wei Lu, Fenghua Cao, Bo Shen, Ge Song, Zhihong Chen, Huaxi Xu, Jie Ma
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Myeloid-derived suppressor cells (MDSCs) are derived from bone marrow progenitor cells commonly, which is a heterogeneous cell group composed of immature granulocytes, dendritic cells, macrophages and early undifferentiated bone marrow precursor cell
Autor:
Jonathan D. Leavenworth, Michael L. Dixon, Sadashib Ghosh, Lin Luo, Jeffrey M. Grimes, Jianmei W. Leavenworth
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-24 (2021)
Background Accumulation of Foxp3+ regulatory T (Treg) cells in the tumor often represents an important mechanism for cancer immune evasion and a critical barrier to anti-tumor immunity and immunotherapy. Many tumor-infiltrating Treg cells display an
Autor:
Bing Chen, Jingjing Zhao, Qin Li, Yuchen Li, Qiupeng Zheng, Hongyan Lai, Siyuan Chen, Shenglin Huang, Xiao-Dong Zhu, Yan Li
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-22 (2021)
BMC Cancer
BMC Cancer
Background Viral infections are prevalent in human cancers and they have great diagnostic and theranostic values in clinical practice. Recently, their potential of shaping the tumor immune microenvironment (TIME) has been related to the immunotherapy
Autor:
Stephanie Humblet-Baron, Stanislas Goriely, Pieter Pannus, B. Willems, Leo Heyndrickx, Sophie Servais, Kevin K. Ariën, Lorenzo Canti, Grégory Ehx, Adrian Liston, Johan Michiels, Aurélie Henry, Yves Beguin, Maria E Goossens, Arnaud Marchant, Frédéric Baron, Evelyne Willems, Isabelle Desombere, Julika Neumann, Laurence Seidel
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-12 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology, 14 (1
Journal of Hematology & Oncology
Journal of Hematology & Oncology, 14 (1
Background Factors affecting response to SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem cell transplantation (allo-HCT) recipients remain to be elucidated. Methods Forty allo-HCT recipients were included in a study of immunization with BNT1
Autor:
Young Seok Baek, Hee Jung An, Heejoo Jang, Daun Jung, Yong-Soo Choi, Ki Yeon Kim, Sohyun Hwang, Jieun Jung, In Jee Lee, Kyung-Soon Park, Yong-Wha Moon
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-14 (2021)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
BackgroundRecently, allogeneic natural killer (NK) cells have gained considerable attention as promising immunotherapeutic tools due to their unique biological functions and characteristics. Although many NK expansion strategies have been reported pr
Autor:
Zehua Wang, Qiulei Wu, Ya Zeng, Jing Cai, Xiaohan Xu, Xiaoqi He, Linjuan Xu, Guoqing Li, Lanqing Gong
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-15 (2021)
Cancer Cell International
Cancer Cell International
Background Pelvic lymph node metastasis (LNM) is a crucial independent prognostic factor in cervical cancer (CCa) and serves as an indicator for radiation therapy as the primary or an adjuvant treatment option. However, preoperative diagnosis of LNM
Autor:
Siyang Wang, Zhigang Liu, Ya-qin Zhang, Yu-jing Lin, Rong Wang, Wei Wei, Xi-Wei Xu, Gui-hua Zhong, Hai-yu Hong, Qiao-Dan Liu, Ye Liu, Ying-peng Peng, Shun-li Peng, Yu-ling Zhou
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background Second head and neck neuroendocrine carcinoma (NEC) after radical radiotherapy for nasopharyngeal carcinoma (NPC) treatment is rarely reported. The prognosis of second cancer is poor, and our research focuses on finding a breakthrough in t
Autor:
Koichi Takeda, Brian Hayama, Toshiharu Sasaki, Kenji Nakano, Daisuke Ohkushi, Kosuke Hoashi, Koh Okamoto, Taisuke Enokida, Sohei Harada
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background Pneumocystis jirovecii pneumonia (PCP)-related risk factors among patients with solid tumors are not completely defined. Thus, we aimed to characterize PCP cases with underlying solid tumors, to highlight the factors contributing to its de
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background Paclitaxel (Taxol) is a microtubule-stabilizing drug used to treat several solid tumors, including ovarian, breast, non-small cell lung, and pancreatic cancers. The current treatment of ovarian cancer is chemotherapy using paclitaxel in co
Autor:
Hemavathi Dhandapani, Selvaluxmy Ganeshrajah, Priya Ramanathan, Rajkumar Thangarajan, Anil Suri, Hascitha Jayakumar, Shirley Sunder Singh, Nirmala Jagadish, Abirami Seetharaman
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-14 (2021)
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the tumor. However, major limitations are the availability of autologous tumor